Merck Sharp & Dohme Corporation v. Albrecht
Pending petition
Issue: Whether, if a pharmaceutical manufacturer fully informs the Food & Drug Administration of all material information bearing on a drug’s potential risk and seeks approval to warn of that risk on the label, but the FDA formally denies the request without mandating any alternative warning, the manufacturer may nonetheless be held liable under state law for failure to warn of that risk.
| Date | Proceedings and Orders |
|---|---|
| 01/16/2025 | Application (24A720) to extend the time to file a petition for a writ of certiorari from February 17, 2025 to March 19, 2025, submitted to Justice Alito. |
| 01/24/2025 | Application (24A720) granted by Justice Alito extending the time to file until March 19, 2025. |
| 03/10/2025 | Petition for a writ of certiorari filed. (Response due April 11, 2025) |
| 04/02/2025 | Motion to extend the time to file a response from April 11, 2025 to May 12, 2025, submitted to The Clerk. |
| 04/03/2025 | Motion to extend the time to file a response is granted and the time is extended to and including May 12, 2025. |
| 04/11/2025 | Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed. |
| 04/11/2025 | Brief amicus curiae of Washington Legal Foundation filed. |
| 04/11/2025 | Brief amicus curiae of Product Liability Advisory Council, Inc. filed. |